First scientific-backed technology to assess movement in continuum...
> read more
Pioneering remote monitoring platform helps Parkinson’s Nurses to prioritize patients and eases the burden on nurses.
Award-winning new digital technology, with UK operations in Sheffield was exhibited at PDNSA Conference (Parkinson’s Disease Nurse Specialist Association) between the 11-12th Oct,...
Certest renews its corporate identity
MEDICA 2022, the world's largest exhibition event for the health sector, has been the starting point chosen by the firm to introduce its new corporate identity.
Cepheid Receives CE Mark for Xpert® Xpress GBS
Redesigned test introduces two new targets to improve coverage and sensitivity for Group B Streptococcus testing for pregnant females
Mindray Partners With Randox on the New Chemistry Parameters
Mindray, a world-leading developer, manufacturer and supplier of medical devices and solutions, is pleased to announce a partnership with Randox, a global market leader in the...
Boston Scientific Expands Diagnostics Offerings in Europe with Launch of LUX-Dx™ Insertable Cardiac Monitor System
Dual-stage algorithm detects and verifies potential heart arrhythmias to help increase clinical efficiency
DIASORIN COMMERCIALIZES MOLECULAR REAGENT FOR MONKEYPOX VIRUS
Saluggia, Italy - DiaSorin (FTSE MIB: DIA) announces its release of an Analyte Specific Reagent (ASR) primer pair that detects the B17R/B18R gene of the monkeypox virus, the...
Thermo Fisher Scientific to Acquire The Binding Site Group
Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma Complements Existing Specialty Diagnostics Offering...
ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
BERLIN, Germany -- Following the success of the Gibco™ Freedom™ CHO-S Cell Line Development Kit, ProBioGen and Thermo Fisher Scientific have teamed up again to develop an even...
Début of the MEDICA SPORTS HUB – Learning by competing with free coaching by successful Olympic athletes
Federal Minister of Health Lauterbach opens 45th German Hospital Day – many celebrities in the MEDICA accompanying programme
DePuy Synthes Receives FDA Clearance for TELIGEN™ System
New MedTech Advancement Brings First-of-Its-Kind Technology to Spine Surgeons, Delivering Advanced Visualization and User-Centric Procedural Control
FDA Accepts NMP's Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis
- Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics -
Groundbreaking Pilot of New Friendly™ Mosquitoes Demonstrates 96% Suppression of Dengue-spreading Aedes aegypti in Urban Communities in Brazil
OXFORD, England -- Oxitec Ltd, a leading developer of biological pest control solutions, today announced the scientific publication of results from groundbreaking large-scale...
RZNOMICS Inc. received FDA approval to initiate clinical development of trans-splicing ribozyme-based RNA editing technology in liver cancer patients
SEONGNAM, South Korea -- Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, recently received Phase 1/2a...
SQI Diagnostics Announces Health Canada Approval of RALI-Dx Severity Triage Test
TORONTO - SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests,...
Medtronic first to receive FDA approval for pacing the heart’s natural conduction system
Medtronic “conduction system pacing” expanded indication now includes left bundle branch area pacing in addition to His-Bundle pacing for patients with slow heart rates
Australia Begins a Big Push to Sequence Underserved Populations
Illumina will support the OurDNA initiative to improve disease prediction, diagnosis, and treatment
Randox collaborate with Verv Technologies to Improve Health for All
Randox Laboratories, the largest diagnostics company from the UK, are proud to announce a $3.8m CAD seed round with Verv Technologies.
Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use
Basel, 12 October 2022- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (“2.0”) for self-testing...
Thermo Fisher Scientific Launches CE-IVD Marked Panel to Detect Most Common Gastrointestinal Bacteria
CARLSBAD, Calif.--(BUSINESS WIRE)-- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the TaqPath Enteric Bacterial Select Panel, a...